Literature DB >> 33841556

The prevalence of asymptomatic carriers of COVID-19 as determined by routine preoperative testing.

Joshua A Bloom1, Zachary Erlichman2, Tina Tian1, Shira Doron1, Lilian Chen1, Kristen Mansur1, Michael E Tarnoff1.   

Abstract

BACKGROUND: The coronavirus disease SARS-CoV-2 (COVID-19) has swiftly spread throughout the globe, greatly influencing all aspects of life. As in previous pandemics, concerns for limited resources and a sustainable medical workforce have been on the forefront of infrastructure modifications. Consequently, surgical specialties have needed to consider each surgical case for necessity and safety during the COVID-19 outbreak. At our institution, availability of SARS-CoV-2 assay has allowed preoperative testing of asymptomatic surgical patients. AIM/
OBJECTIVE: To better define the prevalence of asymptomatic carriers in a surgical population and to better understand the impact of testing on our personal protective equipment (PPE) supply.
METHODS: We began routine, preoperative testing for all asymptomatic patients coming to our academic medical centre on 30 March 2020. Scheduled surgeries were deemed urgent by the surgeon with a review for appropriateness by a novel surgical committee. A retrospective patient chart review was performed. Emergency surgeries were excluded. Asymptomatic patients with positive test results had their surgeries rescheduled at the discretion of the surgeon and patient. Patients who tested negative underwent surgery with staff using standard PPE.
RESULTS: Eighty-four asymptomatic surgical patients were tested preoperatively with three (3.6%) testing positive for SARS-CoV-2. Preoperative testing saved 498 N95 respirators over this time period. DISCUSSION: This is the first report of routine COVID-19 preoperative testing in an asymptomatic surgical population. Within this population, there is a 3.6% rate of asymptomatic SARS-CoV-2 carriers. Through this practice, personnel exposure can be minimised and access to PPE can be preserved.
© The Author(s) 2020.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; asymptomatic carrier; personal protective equipment; preoperative testing

Year:  2020        PMID: 33841556      PMCID: PMC7841708          DOI: 10.1177/1757177420967096

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  10 in total

Review 1.  Ethics and severe pandemic influenza: maintaining essential functions through a fair and considered response.

Authors:  Nancy E Kass; Jean Otto; Daniel O'Brien; Matthew Minson
Journal:  Biosecur Bioterror       Date:  2008-09

2.  Practical considerations in the anaesthetic management of patients during a COVID-19 epidemic.

Authors:  S Ong; T T Khee
Journal:  Anaesthesia       Date:  2020-04-09       Impact factor: 6.955

3.  Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village.

Authors:  Michael Day
Journal:  BMJ       Date:  2020-03-23

4.  Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.

Authors:  Emily Degli-Angeli; Joan Dragavon; Meei-Li Huang; Danijela Lucic; Gavin Cloherty; Keith R Jerome; Alexander L Greninger; Robert W Coombs
Journal:  J Clin Virol       Date:  2020-05-28       Impact factor: 3.168

5.  Resource allocation during an influenza pandemic.

Authors:  Karthikeyan Paranthaman; Christopher P Conlon; Claire Parker; Noel McCarthy
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

6.  Risk of COVID-19 for patients with cancer.

Authors:  Hanping Wang; Li Zhang
Journal:  Lancet Oncol       Date:  2020-03-03       Impact factor: 41.316

7.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

8.  Characteristics of COVID-19 infection in Beijing.

Authors:  Sijia Tian; Nan Hu; Jing Lou; Kun Chen; Xuqin Kang; Zhenjun Xiang; Hui Chen; Dali Wang; Ning Liu; Dong Liu; Gang Chen; Yongliang Zhang; Dou Li; Jianren Li; Huixin Lian; Shengmei Niu; Luxi Zhang; Jinjun Zhang
Journal:  J Infect       Date:  2020-02-27       Impact factor: 6.072

9.  Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.

Authors:  Shaoqing Lei; Fang Jiang; Wating Su; Chang Chen; Jingli Chen; Wei Mei; Li-Ying Zhan; Yifan Jia; Liangqing Zhang; Danyong Liu; Zhong-Yuan Xia; Zhengyuan Xia
Journal:  EClinicalMedicine       Date:  2020-04-05

10.  COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period.

Authors:  Ali Aminian; Saeed Safari; Abdolali Razeghian-Jahromi; Mohammad Ghorbani; Conor P Delaney
Journal:  Ann Surg       Date:  2020-07       Impact factor: 13.787

  10 in total
  3 in total

1.  Meta-analysis of COVID-19 prevalence during preoperative COVID-19 screening in asymptomatic patients.

Authors:  Ellen de Bock; Mando D Filipe; Roger K J Simmermacher; A Christiaan Kroese; Menno R Vriens; Milan C Richir
Journal:  BMJ Open       Date:  2022-07-07       Impact factor: 3.006

2.  Incidence of SARS-CoV-2 infection among asymptomatic patients undergoing preoperative COVID testing prior to cancer surgery: ASPECT study.

Authors:  Shraddha Patkar; Saiesh R Voppuru; Shivakumar Thiagarajan; Devayani Niyogi; Hemant S Niranjan; Shravan Nadkarni; Tejpratap Singh; Manish Bhandare; Purvi Thakkar; Jitender Rohila; Sanjay Biswas; Sridhar Epari; Omshree Shetty; Mamta Gurav; Prachi Bapat; Ajay Puri; C S Pramesh
Journal:  J Surg Oncol       Date:  2021-11-16       Impact factor: 2.885

3.  Evaluating the Efficacy of a Screening Protocol for Severe Acute Respiratory Syndrome Coronavirus 2 Virus in Asymptomatic Preoperative/Preprocedural Patients at a Military Hospital.

Authors:  Cooper Barber; Andrew Syski; Jennifer Leaird; R Christopher Call; Ann Williams; Peter Learn
Journal:  Mil Med       Date:  2021-12-11       Impact factor: 1.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.